Beijing Tong Ren Tang Chinese Medicine Co (3613) Stock Statistics & Valuation Metrics

Beijing Tong Ren Tang Chinese Medicine Co has a market cap or net worth of HKD 4.75B. The enterprise value is HKD 3.52B.

Market Cap

HKD 4.75B

Enterprise Value

HKD 3.52B

Beijing Tong Ren Tang Chinese Medicine Co has 837,100,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

837,100,000

Owned by Insiders

―

Owned by Institutions

3.72%

Beijing Tong Ren Tang Chinese Medicine Co’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.66%.

Return on Equity (ROE)

0.09

Return on Assets (ROA)

0.09

Return on Invested Capital (ROIC)

8.66%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

1.98M

Profits Per Employee

520.60K

Employee Count

763

Asset Turnover

0.32

Inventory Turnover

0.44

The current PE Ratio of Beijing Tong Ren Tang Chinese Medicine Co is 10.59. Beijing Tong Ren Tang Chinese Medicine Co’s PEG ratio is -0.94.

PE Ratio

10.59

PS Ratio

2.96

PB Ratio

1.21

Price to FCF

5.27

Price to Operating Cash Flow

5.05

PEG Ratio

-0.94

In the last 12 months, Beijing Tong Ren Tang Chinese Medicine Co had revenue of 1.51B and earned 397.22M in profits. Earnings per share was 0.47.

Revenue

1.51B

Gross Profit

925.58M

Operating Income

472.24M

Pretax Income

504.69M

Net Income

397.22M

EBITDA

574.36M

Earnings Per Share (EPS)

0.47

In the last 12 months, operating cash flow was 969.98M and capital expenditures -41.11M, giving a free cash flow of 928.86M billion.

Operating Cash Flow

969.98M

Free Cash Flow

928.86M

Free Cash Flow per Share

1.11

Beijing Tong Ren Tang Chinese Medicine Co pays an annual dividend of HKD 0.40, resulting in a dividend yield of 6.51%

Dividend Per Share

HKD 0.40

Dividend Yield

6.51%

Payout Ratio

N/A

Free Cash Flow Yield

19.73%

Earnings Yield

9.76%

Beta

0.45

52-Week Price Change

-39.32%

50-Day Moving Average

5.69

200-Day Moving Average

6.78

Relative Strength Index (RSI)

46.21

Average Volume (3m)

1.16M

Beijing Tong Ren Tang Chinese Medicine Co upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 28, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

Jun 12, 2026

Beijing Tong Ren Tang Chinese Medicine Co as a current ratio of 19.65, with Debt / Equity ratio of 3.02%

Current Ratio

19.65

Quick Ratio

13.16

Debt to Market Cap

0.00

Net Debt to EBITDA

-3.66

Interest Coverage Ratio

83.43

In the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co has paid 87.83M in taxes.

Income Tax

87.83M

Effective Tax Rate

0.17

Beijing Tong Ren Tang Chinese Medicine Co EV to EBITDA ratio is 3.91, with an EV/FCF ratio of 2.88.

EV to Sales

1.62

EV to EBITDA

3.91

EV to Free Cash Flow

2.88

EV to Operating Cash Flow

2.76

Beijing Tong Ren Tang Chinese Medicine Co has HKD 2.21B in cash and marketable securities with HKD 125.80M in debt, giving a net cash position of HKD 2.08B billion.

Cash & Marketable Securities

HKD 2.21B

Total Debt

HKD 125.80M

Net Cash

HKD 2.08B

Net Cash Per Share

HKD 2.49

Tangible Book Value Per Share

HKD 4.99

Gross margin is 62.83%, with operating margin of 32.25%, and net profit margin of 27.78%.

Gross Margin

62.83%

Operating Margin

32.25%

Pretax Margin

34.16%

Net Profit Margin

27.78%

EBITDA Margin

41.36%

EBIT Margin

32.47%

The average price target for Beijing Tong Ren Tang Chinese Medicine Co is HKD 10.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

HKD 10.50

Price Target Upside

86.67% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

-20.79%

EPS Growth Forecast

-30.04%

Smart Score

―

AI Score

72